Christian Schmess

7PUBLICATIONS
21CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMicrofluidics and nanofluidicsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 18, 2023
Breast cancer patient-derived microtumors resemble tumor heterogeneity and enable protein-based stratification and functional validation of individualized drug treatment.

Nicole Anderle, Felix Schäfer-Ruoff, Annette Staebler

|Aug 16, 2023
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy.

Siri Amanda Tvingsholm, Marcus Svensson Frej, Vibeke Mindahl Rafa

|Sep 23, 2022
Protein Profiling of Breast Carcinomas Reveals Expression of Immune-Suppressive Factors and Signatures Relevant for Patient Outcome.

Felix Ruoff, Nicolas Kersten, Nicole Anderle

|Jun 24, 2022
A Platform of Patient-Derived Microtumors Identifies Individual Treatment Responses and Therapeutic Vulnerabilities in Ovarian Cancer.

Nicole Anderle, André Koch, Berthold Gierke

|Jun 09, 2022
Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma.

Anna Reustle, Lena-Sophie Menig, Patrick Leuthold

|Sep 25, 2021
Parallelizable Microfluidic Platform to Model and Assess In Vitro Cellular Barriers: Technology and Application to Study the Interaction of 3D Tumor Spheroids with Cellular Barriers.

Arya Lekshmi Nair, Lena Mesch, Ingo Schulz

Pageof 2

Frequent Collaborators

2 joint publications

Sara Y Brucker

2 joint publications

Nicole Anderle

2 joint publications

André Koch

1 joint publications

Hannes Becker